Top

Reactions Weekly

Published in:

01-04-2024 | Portal Hypertension | Case report

Furosemide/Propranolol/Spironolactone

Lack of efficacy

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Marrero Santiago EI, et al. WCN24-359 Uncommon Alliance: Portal Hypertension in Diabetic Nephropathy-Related Nephrotic Syndrome with a Healthy Liver. Kidney International Reports 9: S509-S510 abstr. WCN24-359, No. 4, Apr 2024. Available from: URL: https://www.kireports.org/article/S2468-0249(24)01152-5/fulltext [abstract]

Title: Furosemide/Propranolol/Spironolactone
Lack of efficacy
Publication date: 01-04-2024
Publisher: Springer International Publishing
Keywords: Portal Hypertension
Portal Hypertension
Spironolactone
Furosemide
Propranolol
Ascites
Portal Vein Thrombosis
Portal Vein Thrombosis
Nephrotic Syndrome
Chronic Kidney Disease
Hepatorenal Syndrome
Hepatorenal Syndrome
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-56855-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Furosemide/Propranolol/Spironolactone

Lack of efficacy

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Multiple drugs

Evolocumab

Levonorgestrel

Multiple drugs

Ondansetron

Baricitinib